Friday, December 19, 2025 | 09:44 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Pfizer's Covid vaccine effectiveness claims inject hope, lift global stocks

Firms hit hardest by restrictions made most gains, with airlines trading 30% higher

Coronavirus, vaccine, covid, drugs, clinical trials
premium

The S&P 500 and the Dow hit record highs on Monday as the first successful late-stage clinical trial of a Covid-19 vaccine sparked hopes of the economy emerging from a pandemic-driven crisis

Rita Nazareth & Vildana Hajric | Bloomberg
Stocks surged around the world and bonds tumbled after a large-scale coronavirus vaccine study delivered the most-promising results in the battle against the worst pandemic in a century.

Equities came off session highs after Mayor Bill de Blasio said New York City is coming “dangerously close” to a second wave of the coronavirus. 

Still, more than 85 per cent of S&P 500 companies climbed on Monday as the gauge jumped to a record on news that the Covid-19 shot being developed by Pfizer and BioNTech prevented more than 90 per cent of infections. 

The S&P 500 and the Dow hit record highs on